CN105796718A - Skin care agent and preparation method thereof - Google Patents
Skin care agent and preparation method thereof Download PDFInfo
- Publication number
- CN105796718A CN105796718A CN201610231485.4A CN201610231485A CN105796718A CN 105796718 A CN105796718 A CN 105796718A CN 201610231485 A CN201610231485 A CN 201610231485A CN 105796718 A CN105796718 A CN 105796718A
- Authority
- CN
- China
- Prior art keywords
- parts
- care agent
- skin
- preparation
- skin care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a skin care agent and a preparation method thereof.The skin care agent is mainly prepared from, by weight, 150-250 parts of corn flour, 10 parts of rhizoma coptidis, 10 parts of scutellaria baicalensis, 10 parts of amur cork tree bark and 10 parts of safflowers.The preparation method of the skin care agent includes the following steps that the corn flour is made, wherein non-transgenic corn starch is taken, and washing with distilled water, filtering, throw filtering, smashing and screening, drying and high-temperature sterilization are conducted; 2, medicine powder is made, wherein 10 parts of rhizoma coptidis, 10 parts of scutellaria baicalensis, 10 parts of amur cork tree bark and 10 parts of safflowers are taken and each subjected to rinsing, medicine moistening, medicine cutting, drying, secondary rinsing, secondary drying, smashing and screening, drying and high-temperature sterilization; 3, 150-250 parts of the corn flour made in the step 1, and 10 parts of the fine rhizoma coptidis medicine powder, 10 parts of the fine scutellaria baicalensis medicine powder, 10 parts of the fine amur cork tree bark medicine powder and 10 parts of the fine safflower medicine powder made in the step 2 are taken and mixed to be uniform through a stirrer.The skin care agent has the advantages that the immune state of skin can be improved, the skin care agent is safe and free of toxic and side effects, and the preparation method is simple.
Description
Technical field
The invention belongs to clinical care technical field, especially relate to a kind of skin-care agent and preparation method thereof.
Background technology
The many hemiplegia of paralytic, bed, incontinence of urination and defecation, occur pressure ulcer, diaper dermatitis risk relatively big, occur the two easily to cause again infection, making patients's state of an illness, extend hospital day；Care product currently for pressure ulcer, children's's diaper dermatitis is more, but the care product for older paralytic's Bedsore prevention, diaper dermatitis needs to research and develop.
Now mostly adopting external mode for the nursing of pressure ulcer, prevent mainly through alleviating skin pressure, as air fluidized bed, decompression are pasted, stood up, but these can not stop the generation of pressure ulcer completely, still has skin blister to occur and the situation of ulceration.
The present invention is from improving patient skin situation, and prevention skin infection ulceration is set about, and is one to exopathogenic factor prevention and well supplements, to obtain better nursing efficacy.
Summary of the invention
It is an object of the invention to provide a kind of skin-care agent safe and free of toxic and side effects and preparation method thereof, be especially suitable for the prevention nursing of paralytic's pressure ulcer.
The technical scheme is that
A kind of skin-care agent of the present invention, is mainly made up of the raw material of following weight portion: Semen Maydis powder 150～250 parts, Rhizoma Coptidis 10 parts, Radix Scutellariae 10 parts, Cortex Phellodendri 10 parts, 10 parts of Flos Carthami.
The preparation method that another aspect of the present invention also includes a kind of described skin-care agent, comprises the following steps:
(1) making of Semen Maydis powder: negated transgenic cornstarch, washes through distilled water, filters, rejection filter, pulverizes and sieves, dry, and high temperature sterilize processes, and obtains Semen Maydis powder；
(2) making of medicated powder: take Rhizoma Coptidis 10 parts, Radix Scutellariae 10 parts, Cortex Phellodendri 10 parts, 10 parts of Flos Carthami, processes respectively according to the following steps: rinsing, demulcen, cuts medicine, dries, and secondary rinses, and secondary drying pulverizes and sieves, dry, and high temperature sterilize processes, and obtains thin medicated powder；
(3) take each 10 parts of the thin medicated powder that the prepared Semen Maydis powder 150～250 parts of step (1) prepares with step (2), utilize blender to mix.
Preferably, described step (1) crosses 120 mesh sieves after pulverizing, and adopts 110 DEG C of high temperature sterilizes to process, and the Semen Maydis powder moisture obtained is less than 9%.
Preferably, pulverizing 120 mesh sieves in described step (2), and adopted 110 DEG C of high temperature sterilizes to process, the thin medicated powder moisture obtained is less than 9%.
Preferably, described step (3) adopts the mixing of equal increments method.
The present invention has the advantage that and has the benefit effect that
1. replace Pulvis Talci, safety with Semen Maydis powder, have no side effect, the pulmonary caused because of the talc particle sucking tradition talcum powder by mistake can be avoided to stimulate.
2. skin nursing powder adds ingredient, containing compositions such as Rhizoma Coptidis, Radix Scutellariae, Cortex Phellodendris in inventive formulation, it has antiinflammatory, removes the intrinsic property of heart-fire, thus so as to have the effect diminishing inflammation from self, adjusting self reparation power, simultaneously because heart-fire is relevant with pruritus, thus reaching to remove pruritus, adjust the effect of autoimmune function；Flos Carthami has blood circulation promoting and blood stasis dispelling, improve local compression SkBF and nutrition altogether to effect.Above four Chinese medicine thing can while dry skin after being added, and removing damp-heat, blood circulation promoting and blood stasis dispelling improve local compression SkBF, while improving exopathogenic factor, improve skin idiotrophic immune state, be more beneficial for the maintenance of skin integrity.
Detailed description of the invention
A kind of skin-care agent of the present invention, including following component: Semen Maydis powder 150～250 grams, Rhizoma Coptidis 10 grams, Radix Scutellariae 10 grams, Cortex Phellodendri 10 grams, 10 grams of Flos Carthami.
The preparation process of the skin-care agent of the present invention, comprises the following steps:
(1) flow process of the making of Semen Maydis powder: non-transgenic cornstarch, wash through distilled water, filter, rejection filter, pulverized 120 mesh sieves, dry, under 110 DEG C of conditions, high temperature sterilize processes, and obtains the moisture Semen Maydis powder less than 9%, this extremely fine and smooth natural plant opaque, it is a kind of well caking inhibiter, existing good hygroscopicity, the dry and comfortable of skin can be kept；Prevented from caking again, does not block sweat gland, moreover it is possible to effectively reduce skin and extraneous friction.
(2) making of medicated powder: Rhizoma Coptidis 10 parts, Radix Scutellariae 10 parts, Cortex Phellodendri 10 parts, 10 parts of Flos Carthami, these four kinds of drug powders are individually prepared, and preparation method is identical, comprise the following steps: rinsing, demulcen, cuts medicine, dries, secondary rinses, secondary drying, pulverized 120 mesh sieves, dry, 110 DEG C of high temperature sterilizes process, and obtain the moisture medicated powder less than 9%；
(3) take totally 40 parts of four kinds of medicated powder that the prepared Semen Maydis powder 150～250 parts of step (1) prepares with step (2), adopt the mixing of equal increments method.
(4) gained medicated powder meets following standard: a moisture is less than 9%；B uniform color, without decorative pattern and mottle；C limit test of microbe meets Chinese Pharmacopoeia requirement.
Above one embodiment of the present of invention is described in detail, but described content has been only presently preferred embodiments of the present invention, it is impossible to be considered the practical range for limiting the present invention.All equalizations made according to the present patent application scope change and improvement etc., all should still belong within the patent covering scope of the present invention.
Claims (5)
1. a skin-care agent, it is characterised in that: mainly it is made up of the raw material of following weight portion: Semen Maydis powder 150～250 parts, Rhizoma Coptidis 10 parts, Radix Scutellariae 10 parts, Cortex Phellodendri 10 parts, 10 parts of Flos Carthami.
2. the preparation method of a skin-care agent, it is characterised in that: comprise the following steps:
(1) making of Semen Maydis powder: negated transgenic cornstarch, washes through distilled water, filters, rejection filter, pulverizes and sieves, dry, and high temperature sterilize processes, and obtains Semen Maydis powder；
(2) making of medicated powder: take Rhizoma Coptidis 10 parts, Radix Scutellariae 10 parts, Cortex Phellodendri 10 parts, 10 parts of Flos Carthami, processes respectively according to the following steps: rinsing, demulcen, cuts medicine, dries, and secondary rinses, and secondary drying pulverizes and sieves, dry, and high temperature sterilize processes, and obtains thin medicated powder；
(3) take each 10 parts of the thin medicated powder that the prepared Semen Maydis powder 150～250 parts of step (1) prepares with step (2), utilize blender to mix.
3. the preparation method of a kind of skin-care agent according to claim 2, it is characterised in that: pulverizing 120 mesh sieves in described step (1), and adopted 110 DEG C of high temperature sterilizes to process, the Semen Maydis powder moisture obtained is less than 9%.
4. the preparation method of a kind of skin-care agent according to claim 2, it is characterised in that: pulverizing 120 mesh sieves in described step (2), and adopted 110 DEG C of high temperature sterilizes to process, the thin medicated powder moisture obtained is less than 9%.
5. the preparation method of a kind of skin-care agent according to claim 2, it is characterised in that: described step (3) adopts the mixing of equal increments method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610231485.4A CN105796718A (en) | 2016-04-10 | 2016-04-10 | Skin care agent and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610231485.4A CN105796718A (en) | 2016-04-10 | 2016-04-10 | Skin care agent and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105796718A true CN105796718A (en) | 2016-07-27 |
Family
ID=56460151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610231485.4A Pending CN105796718A (en) | 2016-04-10 | 2016-04-10 | Skin care agent and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105796718A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112933030A (en) * | 2021-02-05 | 2021-06-11 | 湖北特必达生物医疗科技有限公司 | Skin care agent and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102302678A (en) * | 2011-09-15 | 2012-01-04 | 何大明 | Skin membrane repair drug |
| CN102579650A (en) * | 2011-03-10 | 2012-07-18 | 成都中医药大学 | Medicinal composition for preventing or/and treating pressure sore, as well as preparation method and application thereof |
| CN102626374A (en) * | 2012-04-28 | 2012-08-08 | 佛山拜澳生物科技有限公司 | Medical skin care agent and preparation method thereof |
-
2016
- 2016-04-10 CN CN201610231485.4A patent/CN105796718A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579650A (en) * | 2011-03-10 | 2012-07-18 | 成都中医药大学 | Medicinal composition for preventing or/and treating pressure sore, as well as preparation method and application thereof |
| CN102302678A (en) * | 2011-09-15 | 2012-01-04 | 何大明 | Skin membrane repair drug |
| CN102626374A (en) * | 2012-04-28 | 2012-08-08 | 佛山拜澳生物科技有限公司 | Medical skin care agent and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112933030A (en) * | 2021-02-05 | 2021-06-11 | 湖北特必达生物医疗科技有限公司 | Skin care agent and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104739777B (en) | A kind of preparation method of single medicinal material powder | |
| CN103432248B (en) | Health-care product for protecting liver from alcohol damage and nourishing stomach and preparation method thereof | |
| WO2010054520A1 (en) | Pharmaceutical composition for purifing vein and preparation method thereof | |
| KR20060099576A (en) | How to making atory dermatitis treatment function pack | |
| CN100536888C (en) | Traditional Chinese medicine preparation for treating chronic nephritis and nephrotic syndrome | |
| CN101491614B (en) | Traditional Chinese medicine composition for treating mouth and tongue sore and stomatocace | |
| CN105796718A (en) | Skin care agent and preparation method thereof | |
| CN103655390A (en) | Talcum powder containing herbal natural components and preparation process thereof | |
| KR20100090422A (en) | Pill of bean-paste soup prepared with ground fermented soybeans contained oriental medicines and method for preparing thereof | |
| CN104258237A (en) | Traditional Chinese medicine composition for treating anaphylactoid purpura as well as preparation method and application of traditional Chinese medicine composition | |
| CN104383068A (en) | High-efficiency, antiviral and bacteriostatic traditional Chinese veterinary medicine | |
| KR20140143952A (en) | Arthritis Remedy Composition and manufacture method having immunity and the circulation of the blood improvement fuction | |
| CN105695171A (en) | Baby product cleaning agent and preparation method thereof | |
| CN104840910B (en) | A kind of composition and method of making the same for the treatment of early pregnancy vomiting | |
| CN104399036A (en) | Medicine composition for treating chronic diarrhea and application of medicine composition | |
| CN109999215A (en) | A kind of nano traditional Chinese medicine antibacterial paper diaper | |
| CN104027505A (en) | Method for preparing traditional Chinese medicine facial mask powder for treating pimple | |
| CN106137844A (en) | A kind of infant diaper ointment and preparation method thereof | |
| CN102949554A (en) | Traditional Chinese medicinal composite for treating anaphylactoid purpura | |
| CN106235063A (en) | A kind of compound recipe yak bone powder vitamin D calcium tablet and preparation method thereof | |
| CN102526493A (en) | Medicine for resisting tuberculosis and preparation method thereof | |
| CN107789479A (en) | A kind of Chinese medicine for being used to treat diabetes | |
| CN106266770A (en) | One treats hand-foot-mouth disease process for preparing buccal lozenge | |
| CN111544497A (en) | A Chinese medicinal ointment for treating infantile dermatoses | |
| CN105833076A (en) | Traditional Chinese medicine composition for treating child thrush and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160727 |
|
| RJ01 | Rejection of invention patent application after publication |